THE MOST VALUABLE ASSET IN THE INFRASTRUCTURE
We intend to be the first medical cannabis company to source, market and distribute cannabis as a speciality pharmaceutical product, for precise medical needs, such as Epilepsy, ADHS and Oncology.
This segment represents several million patients with severe conditions, and we forecast that this segment of the market offers; the lower threat of competition, multiple revenue streams, long term value focus and exceptional return on investment.
DISTRIBUTION – Our model will maximise returns as well as vertical integration of production to patient
PHYSICIANS – Prescribe based on the correct treatment option, familiarity with treatment option and the relationship with the provider.
FARM TO PHARMACY – Integrated product development, education, and relationship management for physicians, patients & advocacy groups.